DGAP-News

4SC AG: 4SC enters into licensing and development partnership with Link Health for the cancer compound 4SC 205 in China - Seite 3

industry with the aim of creating market value in China with local
partners. More information can be found at: www.healthinlink.com.

Forward-looking information

This press release contains certain forward-looking statements. Any
forward-looking statement applies only on the date of this press release.
By their nature, forward-looking statements are subject to a number of
known and unknown risks and uncertainties that may or may not occur in the
future and as a result of which the actual results and performance may
differ substantially from the expected future results or performance
expressed or implied in the forward looking statements. No warranties or
representations are made as to the accuracy, achievement or reasonableness
of such statements, estimates or projections, and 4SC AG has no obligation
to update any such information or to correct any inaccuracies herein or
omission herefrom which may become apparent.

Related articles

(http://www.4sc.com/investors/corporate-news/)

3 June 2015, 4SC presents final results from Phase I AEGIS trial as well as
rationale for daily dosing scheme of 4SC-205 cancer compound at ASCO

13 August 2015, 4SC strengthens patent protection for its epigenetic cancer
drug candidate 4SC-202 in growth market China

Contact

4SC AG
Corporate Communications & Investor Relations
Wolfgang Güssgen, [e-mail], [phone]
Dr. Anna Niedl, [e-mail], [phone]

MC Services
Katja Arnold, [e-mail], [phone]

The Ruth Group
Carol Ruth, [e-mail], [phone]


---------------------------------------------------------------------------

31.05.2016 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de

---------------------------------------------------------------------------

Language: English
Company: 4SC AG
Am Klopferspitz 19a
82152 Planegg-Martinsried
Germany
Phone: [phone]
Fax: [phone]
E-mail: [e-mail]
Internet: www.4sc.com
ISIN: DE000A14KL72
WKN: A14KL7
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Munich,
Stuttgart, Tradegate Exchange


End of News DGAP News Service
---------------------------------------------------------------------------

467587 31.05.2016